期刊文献+

淀粉微球(CSM)的制备优化及其缓释性能 被引量:5

Preparation of crosslinked starch microspheres(CSM) and the drug release
下载PDF
导出
摘要 为了优化反相悬浮法合成交联淀粉微球(CSM)的工艺,采用响应曲面法分析了交联剂质量分数(X1)、反应温度(X2)和引发剂浓度(X3)对于CSM溶胀度和平均粒径的影响,建立预测模型。方差分析表明,X1、X2和X3对于CSM品质具有极显著的影响。较优工艺参数为:X1为0.5%,X2为48℃,X3为3.7 mmol/L,对应的CMS溶胀度及平均粒径的预测值分别为246%和16.5μm,与实验值接近,表明应用响应曲面法所得到的CMS合成工艺参数是可行的,将CSM用于盐酸阿霉素(DOX.HCl)的包载,显示良好的缓释效果。 The response surface methodology was employed to analyze the effects of dosage of crosslinking agent, temperature and initiator concentration on the starch microspheres CSM to derive optimum conditions swelling ratio and the partical size of crosslinked for oreoaration of CSM. And the prediction model was established. The optimum conditions were as follows: amounts of crosslinking agent 0.5%, reaction temperature 48℃ and initiator concentration 3.7 mmol/L. Values predicted by the models for the rate of swelling ratio and the partical size of CSM under optimized conditions were 246% and 16.5μm, respectively. These values were experimentally verified, and the predicted values were good agreement with experimental values. And then CSM was used to encapsulate DOX · HCl which showed good performance in drug release test.
作者 秦蓓
出处 《应用化工》 CAS CSCD 2011年第9期1512-1515,共4页 Applied Chemical Industry
基金 国家自然科学基金资助项目(50573046) 陕西科技厅社会发展攻关项目(2010K17-04-01)
关键词 淀粉微球 响应面法 DOX·HCl crosslinked starch microspheres( CSM) response surface methodology DOX · HCl
  • 相关文献

参考文献14

  • 1张跃华,王南平,张其平,王清明,陆天虹.β-环糊精与阿霉素相互作用荧光光谱[J].应用化学,2011,28(3):343-348. 被引量:4
  • 2马素德,郭焱,李仲谨,邱维,曹直.淀粉微球的用途及发展建议[J].化工新型材料,2003,31(10):6-8. 被引量:41
  • 3栾瀚森,王浩,侯惠民.生物降解微球的制备工艺及释药特性研究进展[J].中国医药工业杂志,2004,35(8):496-501. 被引量:3
  • 4Shiba H, Okamoto T, Futagawa Y, et al. Adenovirus vector-mediatedgene transfer using degradable starch microspheres for heap tocellutar carcinoma in rats [ J ]. J Surg Res ,2006,133 (2) : 193-196.
  • 5Malafaya P B, Stappers F, Reis R L. Stareh-based microspheres produced by emulsion cmsslinking with a potential media dependent responsive behavior to be used as drug delivery carfiers[J]. J Mater Sci Mater Med,2006, 17(4) :371-377.
  • 6Lidia Elfstrand, Ann-Charlotte Eliasson, Monica Jonsson, et al. From starch to starch micmspheres : Factors controlling the micmspheres quality [ J ]. Starch/Starke, 2006, 58:381-390.
  • 7Hamdi G, Ponchel G, Duchene D. Formulation of epichlorohydfin crosslinked starch microspheres [ J ]. Journal of Microencapsulation ,2001,18 ( 3 ) : 373-383.
  • 8于九皋,田汝川,刘延奇.阴离子型淀粉微球的合成及性能研究[J].高等学校化学学报,1994,15(4):616-619. 被引量:35
  • 9Shirui Mao, Jianming Chen, Zhenping Wei, et al. Intranasal administration of melatonin starch microspheres [ J ]. International Journal of Pharmaceutics, 2004,272 ( 1/2 ) : 37- 43.
  • 10赵新法,李仲谨,李晓钡,王磊,刘节根.修饰碳糊电极研究载药淀粉微球的吸附机理[J].陕西科技大学学报(自然科学版),2006,24(4):4-7. 被引量:7

二级参考文献70

共引文献115

同被引文献54

  • 1邱礼平,马细兰,温其标.乙酰水杨酸磁性淀粉微球性能及磁动力学运动的研究[J].现代化工,2007,27(z1):165-168. 被引量:5
  • 2毛世瑞,刘欢,陈建明,魏振平,毕殿洲.褪黑激素鼻腔给药淀粉微球的制备工艺[J].沈阳药科大学学报,2004,21(5):324-327. 被引量:7
  • 3郝文利,李培锋.解热镇痛药的发展概况[J].动物医学进展,2006,27(6):45-49. 被引量:7
  • 4杨莉,高颖昌,赵志刚.鼻腔给药的研究进展[J].中国药学杂志,2006,41(22):1685-1688. 被引量:33
  • 5李仲谨,蔡京荣,韩敏.两步交联法制备淀粉微球的研究[J].食品科技,2007,32(7):45-49. 被引量:4
  • 6da Fonseca C O,Landeiro J A,Clark S S,et al. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol[J]. Surgical Neurology, 2006,65 (S1):2-8.
  • 7Pereswetoff-Morath L Microspheres as nasal drug delivery systems[J]. Advanced Drug Delivery Reviews, 1998,29 (1-2):185- 194.
  • 8Fournier C, Hamon M, Hamon M, et al. Preparation and predinical evaluation of bioresorbable hydroxyethylstareh microspheres for transient arterial embolization[J]. International Journal of Pharmaceutics, 1994,106(1):41-49.
  • 9Shiba H, Okamoto T, Futagawa Y, et al. Adenovirus vector-mediated gene transfer using degradable starch mlcrospheres for heap to cellular carcinoma in rats[J].J Surg Res, 2006, 133 (2): 193- 196.
  • 10Malafaya P B, Stappers F, Reis R L. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery earriers[J]. J Mater Sci Mater Med,2006,17(4):371-377.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部